<DOC>
	<DOCNO>NCT00243477</DOCNO>
	<brief_summary>The purpose study determine effect antidepressive medication ( Escitalopram ) , start preoperatively give 6 month , 6-month 1 year post-operative morbidity mortality coronary artery bypass grafting</brief_summary>
	<brief_title>MOTIV Study- Effect Antidepressive Treatment Escitalopram Patients Undergoing Coronary Artery Bypass Grafting</brief_title>
	<detailed_description>Depression known adverse effect post-operative mortality morbidity coronary artery bypass grafting . Cardiac surgery know cause transient depression patient . The purpose double-blind , randomize study determine effect antidepressive medication ( Escitalopram ) , start preoperatively give 6 month , 6-month 1 year post-operative morbidity mortality coronary artery bypass grafting . Treatment give 21 15 day pre-operatively 6th post-operative month . Morbidity define STS database well mortality check 1 year .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>Patients undergo elective coronary artery bypass surgery &gt; 30 year old Contraindication antidepressive treatment Already treat antidepressive treatment Concomitant cardiac surgery valve replacement etc . Patients anticoagulation therapy Pregnant woman Hepatic insufficiency</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Coronary Artery Bypass</keyword>
	<keyword>Surgery</keyword>
</DOC>